A Phase II Study of Bevacizumab + Sorafenib in Metastatic Breast Cancer
Part of paid clinical trials in Galesburg, Illinois.
- Sponsor
- Hoosier Cancer Research Network
- Study ID
- NCT00632541
- Phase
- PHASE2
- Status
- Terminated
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Sorafenib — DRUGSorafenib 200mg po daily
- Bevacizumab — DRUGBevacizumab 5mg/kg every other week 1 Cycle = 4 weeks
- Imaging — OTHERImaging every third cycle
Study Details
Prior clinical trials involving bevacizumab and sorafenib have demonstrated single agent activity in previously treated advanced breast cancer. This trial will test combined VEGF inhibition with sorafenib and bevacizumab in less heavily pre-treated patients with advanced breast cancer.
Key Dates
- First listed
- Mar 10, 2008
- Start date
- Oct 31, 2007
- Status verified
- Feb 2018
- Primary completion
- Mar 31, 2009
- Completion
- Mar 31, 2009
Study Design
- Enrollment
- 18 participants (actual)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Single Arm ASorafenib 200mg po daily, Bevacizumab 5mg/kg every other week, 1 Cycle = 4 weeks. Imaging every third cycle
Primary Outcome Measure
Progression-Free Survival [ Time Frame: From the start of the treatment until the criteria for disease progression is met (or death occurs) maximum of 24 months ]
Locations (10)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Medical & Surgical Specialists, LLC | Galesburg | Illinois | 61401 | - |
| Oncology Hematology Associates of SW Indiana | Evansville | Indiana | 47714 | - |
| Fort Wayne Oncology & Hematology, Inc | Fort Wayne | Indiana | 46815 | - |
| Indiana University Simon Cancer Center | Indianapolis | Indiana | 46202 | - |
| Quality Cancer Center (MCGOP) | Indianapolis | Indiana | 46202 | - |
| Arnett Cancer Care | Lafayette | Indiana | 47904 | - |
| Horizon Oncology Center | Lafayette | Indiana | 47905 | - |
| Medical Consultants, P.C. | Muncie | Indiana | 47303 | - |
| Northern Indiana Cancer Research Consortium | South Bend | Indiana | 46601 | - |
| Ireland Cancer Center - University Hospitals of Cleveland | Cleveland | Ohio | 44106 | - |
Find similar trials in Galesburg, IL
By condition
By specialty
By research site
Related Studies
- Every Day Counts: A Lifestyle Program for Women With Metastatic Breast CancerRecruiting · Medical College of Wisconsin · Maywood, Illinois
- Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast CancerPHASE1/PHASE2 · Recruiting · Phoenix Molecular Designs · Gilbert, Arizona
- A Study of BTX-A51 in People With Advanced Solid Tumor and Breast CancerPHASE1 · Recruiting · Edgewood Oncology Inc. · Lake Mary, Florida
- CD40 Agonist, Flt3 Ligand, and Chemotherapy in HER2 Negative Breast CancerPHASE1 · Recruiting · University of Texas Southwestern Medical Center · Chicago, Illinois